This article highlights the role of bacterial glycosidases during infections, introducing their use as glycoengineering tools. What potential does this emerging field hold for biotherapeutics?

Take pride in having a clean and shiny (ish) home? Well, while you’re diligently scrubbing your loo and wiping your kitchen ...

A new study published in Biochemistry sheds light on how bacteria regulate their genes, challenging long-held assumptions ...

A recent review by researchers at Philadelphia College of Osteopathic Medicine (PCOM) shows Chlamydia pneumoniae (Cpn) and ...

Type III secretion systems (T3SSs) represent sophisticated nanomachines that bacteria utilise to deliver effector proteins directly into eukaryotic host cells. These multi‐protein assemblies ...

The Bacterial Physiology and Pathogenesis Seminar Series aims to provide a platform for in-depth discussions and presentations on the latest developments in bacterial physiology and pathogenesis. Join ...

Scientists have described the utility of gram-negative bacteria-derived outer membrane vesicles as vaccines and methods to expand their applications.

Michael Mahan's research concerns the molecular mechanisms of bacterial pathogenesis, and immune responses to infection and microbial sepsis. Mahan was co-founder and Director of Remedyne Corporation, ...

Efforts to increase the likelihood of cure have been hindered by an incomplete understanding of the pathogenesis of bacterial vaginosis, although epidemiologic and microbiologic data show that it ...

One in three women are affected by bacterial vaginosis (BV), a common but poorly understood condition caused by an imbalance of vaginal bacteria that can cause discomfort and pain. BV is treated ...

Treating the male sexual partners of women with bacterial vaginosis significantly reduced recurrence, according to an Australian randomized controlled trial that was stopped early for efficacy.